regenerative
Research Use OnlyTB-500 + BPC-157
A bundle of TB-500 and BPC-157 reference compounds for combined research investigation of actin-binding and growth-factor signaling pathways. Sold for laboratory research and identification purposes only. Not for human consumption.
Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Subscribe & save: $170
Quantity
Add 1 more to save 10% per unit
Technical Data
Specifications
Technical Details
Bulk Pricing
Volume Pricing Guide
Quality Assurance
Certificate of Analysis
Certificate of Analysis
COA documentation is being prepared for this product.
Contact research@roehn.co for batch-specific testing data.
Research Overview
About TB-500 + BPC-157
The TB-500 + BPC-157 blend brings together two of the most rigorously studied regenerative peptides into a single co-lyophilized formulation. The scientific rationale is mechanistic complementarity: BPC-157 drives repair through VEGF upregulation, nitric oxide modulation, and extracellular matrix remodeling, while TB-500 operates through actin sequestration and cytoskeletal dynamics that govern cell migration to injury sites.
Preclinical evidence across multiple tissue types — tendon, muscle, gastrointestinal mucosa, and bone — suggests that co-administration may produce outcomes exceeding those observed with either compound alone. This has made the combination a standard reference protocol in regenerative peptide research.
ROEHN formulates this blend at a 1:1 ratio by weight with each component independently verified to 99% HPLC purity prior to co-lyophilization. The single-vial format eliminates reconstitution variability and simplifies multi-peptide study designs. Individual BPC-157 and TB-500 vials are available separately for researchers requiring independent dose titration.
